Home LiteratureArticle Details
PMID: 11514597 Published · ppublish English Journal Article

Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.

The Journal of experimental medicine ·Vol. 194 ·No. 4 ·2001-08-20 ·Pages 393-406

Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W

Abstract

MHC class II (MHCII) molecules play a pivotal role in the induction and regulation of immune responses. The transcriptional coactivator class II transactivator (CIITA) controls MHCII expression. The CIITA gene is regulated by three independent promoters (pI, pIII, pIV). We have generated pIV knockout mice. These mice exhibit selective abrogation of interferon (IFN)-gamma-induced MHCII expression on a wide variety of non-bone marrow-derived cells, including endothelia, epithelia, astrocytes, and fibroblasts. Constitutive MHCII expression on cortical thymic epithelial cells, and thus positive selection of CD4(+) T cells, is also abolished. In contrast, constitutive and inducible MHCII expression is unaffected on professional antigen-presenting cells, including B cells, dendritic cells, and IFN-gamma-activated cells of the macrophage lineage. pIV(-/-) mice have thus allowed precise definition of CIITA pIV usage in vivo. Moreover, they represent a unique animal model for studying the significance and contribution of MHCII-mediated antigen presentation by nonprofessional antigen-presenting cells in health and disease.

MeSH Terms
Animals Base Sequence DNA Primers Enzyme-Linked Immunosorbent Assay Gene Expression Regulation/drug effects Histocompatibility Antigens Class II/genetics Immunohistochemistry Interferon-gamma/pharmacology Macrophages/drug effects,immunology Mice Mice, Knockout Nuclear Proteins Promoter Regions, Genetic Trans-Activators/genetics,physiology
Chemicals
DNA Primers Histocompatibility Antigens Class II MHC class II transactivator protein Nuclear Proteins Trans-Activators Interferon-gamma
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Waldburger J M
Department of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva 4, Switzerland.
Suter T
Fontana A
Acha-Orbea H
Reith W
References (64)
64 references, click to expand
  1. Primary demyelination in transgenic mice expressing interferon-gamma.
    Nat Med. 1997 Sep;3(9):1037-41 PMID: 9288735
  2. Regulation of transcription of MHC class II genes.
    Curr Opin Immunol. 1997 Feb;9(1):107-13 PMID: 9039770
  3. A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes.
    J Biol Chem. 1999 Nov 5;274(45):32342-50 PMID: 10542275
  4. Regulation of MHC class II expression in the central nervous system.
    Microbes Infect. 1999 Sep;1(11):893-902 PMID: 10614007
  5. MHC class II regulation in vivo in the mouse kidney.
    Microbes Infect. 1999 Sep;1(11):903-12 PMID: 10614008
  6. Advances in gene targeting methods.
    Curr Opin Immunol. 1997 Apr;9(2):183-8 PMID: 9099792
  7. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.
    Immunity. 1998 Feb;8(2):157-66 PMID: 9491997
  8. Quantitative control of MHC class II expression by the transactivator CIITA.
    Eur J Immunol. 1998 Feb;28(2):473-8 PMID: 9521055
  9. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
    J Immunol. 1998 Jan 1;160(1):233-40 PMID: 9551976
  10. Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis.
    J Exp Med. 1998 Aug 3;188(3):597-602 PMID: 9687536
  11. Studies on thymic epithelial cells in vitro.
    Dev Comp Immunol. 1998 May-Jun;22(3):367-77 PMID: 9700465
  12. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.
    Mol Cell Biol. 1999 Jan;19(1):431-40 PMID: 9858567
  13. Mice lacking the transcription factor CIITA--a second look.
    Int Immunol. 1998 Dec;10(12):1957-67 PMID: 9885917
  14. Necrotizing myopathy induced by overexpression of interferon-gamma in transgenic mice.
    Muscle Nerve. 1999 Feb;22(2):156-65 PMID: 10024128
  15. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.
    J Immunol Methods. 1999 Feb 1;223(1):77-92 PMID: 10037236
  16. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    J Immunol. 1999 Apr 15;162(8):4731-9 PMID: 10202014
  17. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    J Immunol. 1999 Sep 1;163(5):2425-31 PMID: 10452977
  18. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    J Neuroimmunol. 1999 Oct 29;99(2):195-204 PMID: 10505975
  19. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 1987 Jun;84(12):4219-23 PMID: 3495802
  20. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.
    Eur J Immunol. 1987 Sep;17(9):1271-8 PMID: 3115791
  21. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.
    Cell. 1988 Mar 11;52(5):773-82 PMID: 2449974
  22. Interferon-gamma in vivo. Induction and loss of class II MHC antigens and immature myelomonocytic cells in rat organs.
    Eur J Immunol. 1988 May;18(5):661-9 PMID: 3132395
  23. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.
    Cell Immunol. 1989 Jan;118(1):108-25 PMID: 2910499
  24. HLA class II antigens: structure, function, and expression in immunodeficiencies, autoimmune diseases, and allograft rejection.
    Adv Nephrol Necker Hosp. 1989;18:325-34 PMID: 2493721
  25. Induction of class II MHC antigen expression in rat organs after systemic application of recombinant gamma interferon.
    Adv Exp Med Biol. 1988;237:795-9 PMID: 3151043
  26. MHC class II expression by the gut epithelium.
    Immunol Today. 1988 Jun;9(6):174-8 PMID: 3151441
  27. Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes.
    J Neuroimmunol. 1989 Dec;25(2-3):209-19 PMID: 2555395
  28. Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization.
    Proc Natl Acad Sci U S A. 1990 Feb;87(4):1615-9 PMID: 2304921
  29. The complex role of epithelial cell MHC class II antigen expression in autoimmune endocrine disease.
    Autoimmunity. 1990;8(2):87-9 PMID: 2104190
  30. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
    Nature. 1992 Oct 22;359(6397):693-9 PMID: 1436033
  31. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  32. Immune response in mice that lack the interferon-gamma receptor.
    Science. 1993 Mar 19;259(5102):1742-5 PMID: 8456301
  33. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.
    Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2779-83 PMID: 8464889
  34. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.
    Int Immunol. 1993 Aug;5(8):957-64 PMID: 8398989
  35. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Cell. 1993 Oct 8;75(1):135-46 PMID: 8402893
  36. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.
    J Pediatr. 1993 Dec;123(6):921-8 PMID: 8229525
  37. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9944-8 PMID: 8234339
  38. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases.
    Crit Rev Immunol. 1993;13(3-4):247-68 PMID: 8110378
  39. Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss.
    Invest Ophthalmol Vis Sci. 1994 May;35(6):2667-81 PMID: 8188461
  40. Assembly, transport, and function of MHC class II molecules.
    Annu Rev Immunol. 1994;12:259-93 PMID: 8011283
  41. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.
    Nucleic Acids Res. 1995 Dec 25;23(24):5080-1 PMID: 8559668
  42. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
    Immunity. 1996 Feb;4(2):167-78 PMID: 8624807
  43. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    J Immunol. 1996 Jun 1;156(11):4254-8 PMID: 8666795
  44. Conditional gene targeting.
    J Clin Invest. 1996 Aug 1;98(3):600-3 PMID: 8698848
  45. Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches.
    Eur J Immunol. 1996 Aug;26(8):1801-6 PMID: 8765024
  46. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.
    Mol Cell Neurosci. 1996 May;7(5):354-70 PMID: 8812062
  47. Major histocompatibility complex class II deficiency: a clinical review.
    Blood Rev. 1996 Dec;10(4):242-8 PMID: 9012922
  48. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.
    J Exp Med. 1997 Feb 3;185(3):541-50 PMID: 9053454
  49. Antigen presentation by parenchymal cells: a route to peripheral tolerance?
    Immunol Rev. 1999 Dec;172:297-314 PMID: 10631955
  50. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis.
    Eur J Immunol. 2000 Mar;30(3):794-802 PMID: 10741394
  51. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
    J Immunol. 2000 Apr 15;164(8):4143-9 PMID: 10754309
  52. Class II transactivator: mastering the art of major histocompatibility complex expression.
    Mol Cell Biol. 2000 Sep;20(17):6185-94 PMID: 10938095
  53. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes.
    Mol Ther. 2000 Oct;2(4):404-14 PMID: 11020357
  54. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
    Immunol Rev. 2000 Dec;178:148-65 PMID: 11213800
  55. The bare lymphocyte syndrome and the regulation of MHC expression.
    Annu Rev Immunol. 2001;19:331-73 PMID: 11244040
  56. MHC and T cell development.
    Rev Immunogenet. 1999;1(1):91-104 PMID: 11256575
  57. Molecular genetics of the Bare lymphocyte syndrome.
    Rev Immunogenet. 2000;2(2):267-82 PMID: 11258423
  58. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.
    J Immunol. 1981 Dec;127(6):2488-95 PMID: 6170707
  59. Inducible expression of H-2 and Ia antigens on brain cells.
    Nature. 1984 Aug 23-29;310(5979):688-91 PMID: 6433204
  60. Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.
    J Immunol. 1985 Jun;134(6):3785-93 PMID: 3921611
  61. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.
    J Exp Med. 1985 Nov 1;162(5):1645-64 PMID: 3932581
  62. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma.
    J Immunol. 1986 Feb 1;136(3):940-8 PMID: 3079804
  63. Organ-specific autoimmunity: a 1986 overview.
    Immunol Rev. 1986 Dec;94:137-69 PMID: 3026954
  64. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
    EMBO J. 1997 May 15;16(10):2851-60 PMID: 9184229
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2001-08-20
Pages
393-406
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193506
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com